Heparin-Induced Thrombocytopenia With Thrombosis After Endovascular Aneurysm Repair

Abstract

Heparin-induced thrombocytopenia is an immune-mediated syndrome that results from unfractionated heparin or low molecular weight heparin exposure. It often remains unrecognized and undertreated and can cause limb and/or life-threatening thrombosis. The authors present 2 cases of thrombosis: one arterial and the other venous that occurred following endovascular abdominal aortic aneurysm repair. To the authors' knowledge, this is only the second report of arterial thrombosis and the first of deep vein thrombosis as a result of heparin-induced thrombocytopenia developing following endovascular abdominal aortic aneurysm repair. This underscores the importance of considering heparin-induced thrombocytopenia as a potential cause for postendovascular thrombotic complications in the patient who develops thrombocytopenia following this procedure.

Keywords

heparin-induced thrombocytopenia EVAR thrombosis DVT limb ischemia

Get full access to this article

View all access options for this article.

References

Warkentin TE Clinical picture of heparin-induced thrombocytopenia. In: Warkentin TE , Greinacher A , eds. Heparin Induced Thrombocytopenia. 3rd ed. New York: Marcel Dekker; 2004:53-106.

Warkentin TE , Levine MN , Hirsh J. , et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin . N Engl J Med. 1995;332:1330-1335.

Lewis BE , Wallis DE , Berkowitz SD , et al. Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia. Circulation. 2001;103: 1838-1843.

Greinacher A. , Volpel H. , Janssens U. , et al. Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study. Circulation. 1999;99:73-80.

Walenga JM , Jeske WP , Messmore HL Mechanisms of venous and arterial thrombosis in heparin-induced thrombocytopenia . J Thromb Thrombolysis. 2000;10(suppl 1):13-20.

Warkentin TE , Sheppard JA , Moore JC , Moore KM , Sigouin CS , Kelton JG Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: how much class do we need? J Lab Clin Med. 2005;146:341-346.

Warkentin TE , Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(suppl):311S-337S.

Levy JH , Hursting MJ Heparin-induced thrombocytopenia, a prothrombotic disease. Hematol Oncol Clin North Am. 2007;21:65-88.

Reininger CB , Greinacher A. , Graf J. , Lasser R. , Steckmeier B. , Schweiberer L. Platelets of patients with peripheral arterial disease are hypersensitive to heparin. Thromb Res. 1996;81:641-649.

10.

Jackson MR , Gillespie DL , Chang AS , Longenecker EG , Peat RA , Alving BM The incidence of heparin-induced antibodies in patients undergoing vascular surgery: a prospective study. J Vasc Surg. 1998;28:439-444; discussion 445.

11.

Lindhoff-Last E. , Eichler P. , Stein M. , et al. A prospective study on the incidence and clinical relevance of heparin-induced antibodies in patients after vascular surgery. Thromb Res. 2000;97:387-393.

12.

Calaitges JG , Liem TK , Spadone D. , Nichols WK , Silver D. The role of heparin-associated antiplatelet antibodies in the outcome of arterial reconstruction. J Vasc Surg. 1999;29:779-785; discussion 785-776.

13.

Chuter TA , Pak LK , Gordon RL , Reilly LM , Messina LM Heparin-induced thrombocytopenia and graft thrombosis following endovascular aneurysm repair. J Endovasc Ther. 2003;10:1087-1090.